Lmr Partners LLP Karuna Therapeutics, Inc. Transaction History

Lmr Partners LLP

  • $10.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$161.01 - $317.85 $3.27 Million - $6.45 Million
20,302 Added 567.73%
23,878 $7.56 Million
Q2 2023

Aug 14, 2023
BUY
$176.32 - $240.22 $630,520 - $859,026
3,576 New
3,576 $775,000
Q2 2021

Aug 16, 2021
SELL
$107.45 - $135.95 $2.15 Million - $2.72 Million
-20,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$95.46 - $133.08 $1.91 Million - $2.66 Million
20,000 New
20,000 $2.41 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email